您当前所在的位置:首页 > 产品中心 > 产品信息
Varenicline tartrate_分子结构_CAS_375815-87-5)
点击图片或这里关闭

Varenicline tartrate

产品号 PZ0004 公司名称 Sigma Aldrich
CAS号 375815-87-5 公司网站 http://www.sigmaaldrich.com
分子式 C17H19N3O6 电 话 1-800-521-8956
分子量 361.34926 传 真
纯 度 ≥98% (HPLC) 电子邮件
保 存 Chembase数据库ID: 154658

产品价格信息

请登录

产品别名

标题
Varenicline tartrate
IUPAC标准名
(1R,12S)-5,8,14-triazatetracyclo[10.3.1.02,11.04,9]hexadeca-2,4,6,8,10-pentaene; (2R,3R)-2,3-dihydroxybutanedioic acid
IUPAC传统名
L(+)-tartaric acid; chantix
别名
Champix
7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino[2,3-h][3]benzazepine tartrate

产品登记号

CAS号 375815-87-5
MDL号 MFCD08460603

产品性质

Empirical Formula (Hill Notation) C13H13N3 · C4H6O6
纯度 ≥98% (HPLC)
外观 white to off-white powder
溶解度 DMSO: >5 mg/mL
GHS危险品标识 GHS09
GHS警示词 Warning
GHS危险声明 H400
欧盟危险性物质标志 有害性(Harmful) 有害性(Harmful) (Xn)
欧盟危险性物质标志 环境危害性(Nature polluting) 环境危害性(Nature polluting) (N)
MSDS下载 下载链接
GHS警示性声明 P273
RID/ADR UN 2811 6.1/PG 1
危险公开号 22-50
安全公开号 22-57
保存温度 room temp
联合国危险货物等级 6.1
联合国危险货物编号 2811
联合国危险货物包装类别(PG) 1
德国WGK号 3

产品详细信息

详细说明 (English)
Legal Information
Sold for research purposes under agreement from Pfizer Inc.
Biochem/physiol Actions
Varenicline tartrate is a partial α4β2 nicotinic receptor agonist and α7 full agonist. Varenicline competitively binds to α4β2 receptors and partially stimulates without creating a full nicotine effect, while simultaneoudly blocking the ability of nicotine to bind to the receptors. Varenicline thus blocks the ability of nicotine to activate α4β2 receptors and stimulate the central nervous mesolimbic dopamine system, believed to be the neuronal mechanism underlying reinforcement and reward experienced upon smoking.
详细说明 (简体中文)
Legal Information
Sold for research purposes under agreement from Pfizer Inc.
Biochem/physiol Actions
Varenicline tartrate is a partial α4β2 nicotinic receptor agonist and α7 full agonist. Varenicline competitively binds to α4β2 receptors and partially stimulates without creating a full nicotine effect, while simultaneoudly blocking the ability of nicotine to bind to the receptors. Varenicline thus blocks the ability of nicotine to activate α4β2 receptors and stimulate the central nervous mesolimbic dopamine system, believed to be the neuronal mechanism underlying reinforcement and reward experienced upon smoking.

参考文献